Semaglutide, a GLP-1 receptor agonist, is widely studied in metabolic disorders, yet its effects in healthy subjects remain unclear. Here, we show that daily administration of semaglutide (0.1 mg/kg) in healthy mice alters behaviour in various tests related to... ...

请注册登录后继续浏览